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Worldwide, about 270 million people are diagnosed with malaria annually and about a million deaths 
occur from this disease mostly in children and pregnant women in Africa. Despite enormous effort and 
resources directed towards malaria control and eradication, problems of resistance to chloroquine by 
the malaria parasite and resistance to insecticide by the mosquito vector have only contributed to 
worsening of the spread of the disease. These problems have led to the search for alternate and 
efficacious mode of treatments with one being vaccine. Previously, sporozoites isolated from 
mosquitoes exposed to 12,000 rads of radiation from a 
137
Cesium source and injected into mice in 
laboratory studies were determine to invade hepatocytes where their development became arrested at 
the trophozoite stage, causing them to confer protection against subsequent challenge with live 
sporozoites. However, attempts to expand these studies in field trials on susceptible human in malaria 
endemic areas has been complicated by the problem of a need for large colonies of mosquitoes that 
can deploy the whole parasite-based vaccine. To circumvent this obstacle, peptide vaccines were 
developed. Unfortunately, only a few of the antigenic determinant on the surface of sporozoites were 
developed as peptide vaccines leading to an efficacy that is inferior to that of the whole parasite-based 
vaccine. Hence, to improve on the efficacy of the peptide vaccine, in this study, axenically-derived 
cultures of P. yoelii EEFs that were incubated as irradiation-attenuated sporozoites and as non-
irradiated sporozoites were subjected to two rounds of suppression subtractive hybridization (SSH) 
along with dot blot analyses and southern blot (RT-PCR) to generate differentially expressed cDNA 
library clones from which peptide antigens will be identified for use in a multi subunit vaccine. 
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Malaria is one of the deadliest of human parasitic 
diseases and results in a high mortality and morbidity rate 
in  tropical   and  sub-tropical   areas   of  the  world.  It  is 
estimated that worldwide, about 270 million new cases of 
malarial infections are diagnosed annually, of which 110 
million  cases  proceed  to develop the disease and about
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one to three million cases finally succumb to the infection 
(WHO, 2016). 
Effort to mitigate the worldwide health burden that 
emanates from malarial infection has been complicated 
by development of resistance by the malaria parasite to 
chloroquine (Wellems 2004), which is  a drug of choice 
for malaria treatment as well as development of 
resistance to insecticides by the Anopheline mosquito 
(Jones and Hoffman, 1994). These problems brought 
about concerted efforts in the scientific community for the 
identification and development of alternate and 
efficacious modes of therapies like vaccine development 
for use to prevent and treat malaria. The process of 
vaccine development for use to treat and prevent malaria 
started in 1945, with the first vaccine that was known as 
the x-irradiated sporozoites vaccine (Spitalny and 
Nussensweig 1972) that was tested in chicken (Taliaferro 
et al., 1945). The success of this first vaccine was later 
replicated in rodents in 1967 (Nussenzweig et al., 1967), 
primates in 1987 (Collins et al., 1989), humans first in 
1973 (Clyde et al., 1973) and then in 1989 to 1999 
(Hoffman et al., 2002). In each of these studies, 
mammalian hosts who were exposed to the irradiation-
attenuated sporozoites developed a protective immunity 
that was elicited against subsequent challenges with 
homologous sporozoites that were fully infectious. 
Unfortunately, the positive results obtained in these 
studies to evaluate the vaccine potential of the irradiation 
attenuated sporozoites were possible because the 
studies were limited to laboratory-maintained animals. 
When it came to obtaining similar results in field studies 
where susceptible humans were exposed to bites from 
sporozoite infected mosquitoes that had been irradiated, 
the process proved to be extremely impractical. The 
rational being that it was easy to manipulate sporozoite 
infected mosquitoes within the confines of a research 
laboratory so that they can deliver whole parasite-based 
vaccine to susceptible laboratory-maintained animals that 
are kept in cages by way of feeding, than to do so with 
susceptible humans in field studies. This is because, in 
order to vaccinate susceptible humans by way of feeding, 
large colonies of infected mosquitoes that have been 
irradiated will be required to deliver whole parasite-based 
vaccines making this process to be cumbersome and 
very challenging for field studies. Equally challenging was 
the problem of how to successfully irradiate as well as 
transport large quantities of sporozoite infected 
mosquitoes to the field without resorting to creating the 
problems of breakthrough of the vaccines. Also 
problematic was the fact that, even if the whole parasite-
based vaccine were to be dissected from the salivary 
gland of the irradiated sporozoite infected mosquitoes 
and cryopreserved for later use to vaccinate susceptible 
individuals by way of needles and syringes, large colonies 
of infected mosquitoes will still be required to be 
maintained. Consequently, to  mitigate  these  challenges  




of the need for large colonies of infected mosquitoes for 
use in field studies to deliver the whole parasite-based 
vaccines, the feasible alternative was that antigenic 
targets on the surface of sporozoites could be identified, 
characterized, and then incorporated into multi-subunit 
vaccines that would provide a protection that is 
comparable to that of the whole parasite-based vaccine. 
The concept to develop vaccines based on antigenic 
targets that are identified on the surface of sporozoites 
for use in multi-subunit vaccines stemmed from studies 
that looked at the developmental process of sporozoites 
in organelles, while they are inside mosquitoes.  These 
organelles are known as micronemes dense body and 
rhoptry bodies (Mota et al., 2002). However, during a 
blood meal, in addition to saliva with anticoagulants that 
are inoculated into the skin of the host by infected 
mosquitoes, sporozoites are equally introduced into the 
skin of susceptible hosts. Immediately inside the skin of 
the host, the sporozoites release the peptides that they 
had synthesized and stored in micronemes, dense body 
and rhoptry bodies while they were inside the body of 
mosquitoes. The released peptides are then used to 
facilitate traversal motility through a wide variety of cell 
types during which there is no invagination of the plasma 
membranes of the affected skin cells. In this traversal 
process, the released peptides are translocated and 
redistributed backward to cover the surface of the body of 
sporozoites as well as deposited at the posterior end in 
such a manner that the peptides remain in continuous 
contact with substrates like integrins (Silvie et al., 2004; 
Dundas et al., 2018) to form a substrate-dependent type 
of movement characterize as gliding motility (Mota et al., 
2002). This type of motility was confirmed by Yamauchi 
et al. (2007) who used video microscopy to document 
sporozoites as they actively breached intact plasma 
membrane of skin cells then enter and exit cells while at 
the same time leaving trails of secreted peptides that 
demarcate the migratory path that has been utilized by 
the sporozoites. 
Incidentally, some of the secreted peptides from the 
micronemes, dense body and rhoptry bodies have been 
identified, their molecular structure determined, and their 
vaccine potential is currently being exploited. Some of the 
identified surface proteins include entities like: the 
circumsporozoite protein (CS) (Khan et al., 1992), 
thrombospondin-related anonymous protein (TRAP) 
(Bhanot et al., 2003; Garcia et al., 2006), sporozoite 
threonine-and asparagine protein (STARP), sporozoite 
microneme protein essential for cell traversal (SPECT) 
and sporozoite and liver-stage antigen (SALSA). 
Furthermore, the vaccine potential of some of the 
secreted peptides like the Sporozoite Microneme Protein 
Essential for Cell Traversal 1 & 2(SPECT1 & 2) (Silvie et 
al., 2008), the Circumsporozoite protein (CS) in the 
SPf66 (Goh et al., 2019) and the RTS, S vaccines 
(Moorthy  et  al., 2004)  as  well  as the Thrombospondin- 
 
 




Related Anonymous Protein (TRAP) in the ME-TRAP 
vaccine have been characterized and evaluated in field 
studies to ascertain their efficacies. 
So far, results from field trials to monitor the efficacies 
of these peptide vaccines have been mixed in terms of 
their ability to provide long lasting protection against 
subsequent challenges with homologous sporozoites that 
were fully infectious. This limited protection has been 
attributed to the fact that of the many antigenic targets 
that are found on the surface of sporozoites, only a few of 
them have been characterized and incorporated into the 
peptide vaccines that are currently being monitored in 
field studies so as to determine their efficacies. Which 
implies that for a peptide vaccine to be efficacious, there 
is the need that it be constituted to include more than just 
the few peptides that are currently being used. In short, 
the peptide vaccines should be constituted to include 
most if not all of the secreted peptides that are involved in 
sporozoite traversal motility through the wide variety of 
cell types of the skin as well as the peptides that are used 
for attachment and invasion of hepatocytes (Pradel et al., 
2002). Once such peptides are identified, characterized, 
and incorporated into multi-subunit vaccines, then will it 
be possible to obtain an efficacy that is comparable to 
that which is obtained from using the whole parasite-
based vaccines (Goswami et al., 2020). 
This need to develop vaccines with efficacies that are 
comparable to that obtained from the whole parasite-
based vaccine is the rationale for studies, which include 
manipulation of certain genes in sporozoites. Some of the 
targeted genes identified and characterized for 
manipulation included genes that code for antigenic 
targets on the surface of sporozoites and the process 
was achieved by way of gene knockout as well as by way 
of genetically attenuated parasites (GAP) (Goh et al., 
2019). The idea to modify sporozoites genetically was to 
abrogate some of those genes that code for peptides that 
are used by sporozoites for traversal motility through skin 
cells and most importantly that are used for attachment 
followed by invasion of hepatocytes. To produce the 
Gene knockout vaccine, the up-regulated in infective 
sporozoite gene-3 and 4 (UIS3and UIS4) were abrogated 
(Mueller, et al., 2005), while to generate the genetically 
attenuated parasites (GAP) vaccine, the targeted genes 
involved were P52 and P36 genes (VanBuskirk et al., 
2009). Unfortunately, to develop these two types of 
vaccines, researchers were confronted with the reality 
that they were going to deal with the very same problem 
that they were trying to avoid, which was the need to 
produce large quantities of sporozoites that made field 
trial of the whole parasite-based vaccines on susceptible 
humans to be cumbersome and impractical.  
Which is why the objective of this study was to 
contribute to vaccine development by the use of 
Suppression subtractive hybridization (SSH) 





identify genes and their antigenic targets that can be 
incorporated into a multi-subunit peptide vaccine rather 
than manipulation of genes that code for antigenic 
determinants on the surface of sporozoites. This is 
significant because unlike in the case with the irradiated 
whole parasite-based vaccine or the genetically modified 
vaccine where a large colony of infected mosquitoes is 
required, with the peptide vaccines, there is no need for a 
large colony of mosquitoes to be maintained.  On the 
contrary, to develop peptide vaccines, the requirement is 
for peptide genes to be identified and their sequences 
determined. The gene sequences can then be cloned 
onto vectors and expressed in bacteria to obtain several 
copies. Similarly, the sequences of antigenic targets on 
the surface of sporozoites can be determined and cloned 
to produce several copies of the peptides. This process 
can be achieved through a onetime use of a colony of 
infected mosquitoes from which sporozoites will be 
dissected from the salivary gland (Goh et al., 2019). Also, 
depending on the number of genes identified and their 
sequences characterized, peptide vaccines develop 
through this process will yield efficacies that are 
comparable to that of the irradiated whole parasite-based 
vaccine. 
To identify genes in sporozoites whose peptides  could 
be incorporated into multi-subunit vaccines in this study, 
a colony of Plasmodium yoelii (17XNL, clone 1.1) 
infected mosquitoes were divided into two batches.  One 
batch of the sporozoite infected mosquitoes were expose 
to 12,000 rads of gamma radiation, while the second 
batch of sporozoite infected mosquitoes were not 
exposed to gamma-irradiation. Sporozoites dissected 
from the salivary glands of infected mosquitoes that were 
irradiated were identified as irradiated exo-erythrocytic 
form (IEEF), while sporozoites dissected from the salivary 
glands of infected mosquitoes that were not exposed to 
gamma-irradiation were identified as non-irradiated exo-
erythrocytic form (NIEEF). The IEEF and the NIEEF were 
cultured axenically for 24  hours prior to RNA extraction. 
The reason being that, in previous studies where non-
irradiated sporozoites were incubated with hepatocytes, 
there was attachment and invasion of hepatocytes by 
sporozoites through a process of invagination of plasma 
membranes to form parasitophorous vacuoles that were 
characterize by bulbous enlargements that progressively 
grew large because the sporozoites transformed to 
trophozoites (Meis et al., 1985) and then to schizonts that 
contain between 10,000 to 30,000 merozoites (Druilhe et 
al., 1998). This transformation by the non-irradiated exo-
erythrocytic forms (NIEEF) resulted in parasitophorous 
vacuoles that measured between 40-45 µm in diameter 
(Scheller et al., 1995). The irradiation-attenuated 
sporozoites when incubated with hepatocytes were 
observed to also attach to and invade hepatocytes by a 
similar process of invagination of the plasma membrane 







µm in diameter (Scheller et al., 1995). The small size of 
the parasitophorous vacuoles was because the 
transformation of the irradiated exo-erythrocytic forms 
(IEEF) became arrested at the trophozoite stage.  
However, a major problem presented in these studies 
was that when attempts were made to isolate and 
characterize antigenic targets that belong solely to 
sporozoites the process became an exercise in futility as 
it was plagued by contamination of sporozoite peptides 
by peptides from hepatocytes (Kaiser et al., 2003).  
To circumvent this problem of contamination by 
peptides from hepatocytes, axenically-derived cultures 
(Kaiser et al., 2003) of P. yoelii EEFs  that were 
incubated as irradiation-attenuated sporozoites and as 
non-irradiated sporozoites were subjected to two rounds 
of suppression subtractive hybridization (SSH) (Galbraith 
et al., 2004) along with dot blot analyses and southern 
blot (RT-PCR) so  as to generate differentially expressed 
cDNA library clones from which genes or peptide 
antigens that are uniquely of sporozoites will be 
identified. This experimental set up was also to decipher 
the molecular basis for the arrest in the development of 
the IEEF at the trophozoite stage in the liver. As result, 
cDNA clones that were randomly selected from the 
differentially expressed genes of the IEEF confirmed by 
displaying reactions that were characterized by up 
regulation of the tubulin tyrosine ligase gene, down 
regulation of the yir gene, abrogation of the erythrocyte 
membrane protein gene and no effect from the gene that 
codes for p235 kDa rhoptry protein, while cDNA clones 
that were randomly selected from differentially expressed 
genes of the NIEEF library confirmed by displaying 
reactions that were characterized by down regulation of 
the tubulin tyrosine ligase gene, up regulation of the yir 
gene, expression of the erythrocyte membrane protein 
gene and no effect on the gene that codes for the p235 
kDa rhoptry protein. 
 
 
MATERIALS AND METHODS 
 
Sporozoite isolation from mosquito 
 
Plasmodium yoelli (17XNL, clone 1.1) infected Anopheles stephensi 
were a gift from the Walter Reed Army Institute of Research (S.S., 
MD).  Infected female Anopheles stephensi mosquitoes were 
exposed to 12,000 rad of gamma radiation from a 
137
Cesium source 
at a dose rate of 833 rad per minute (Shepherd irradiator Mark 1, 
model 68; J.L. Shepherd and Associates, San Fernando, CA). 
Sporozoites were recovered from whole mosquitoes by grinding 
using a mortar and pestle. Sporozoite enrichment was done by 
centrifugation on a renografin-60 gradient (Squib Diagnostics, N.J.) 
for 20 min at 12,000 rpm to remove contaminating mosquito tissue 
and other debris. A 1:5 dilution of sporozoites was counted on a 
haemocytometer.    
 
 
Total RNA and mRNA Isolation   
 
Total RNA and later mRNA  were  obtained  from  sporozoites  after  




homogenization in 1.0 ml of Trizol reagent (Life Technologies, 
Rockville, MD) (Promega, Madison, WI).  Total RNA was isolated 
by chloroform and isopropanol precipitation from the aqueous 
phase followed by washing with 70% ethanol and dilution, using 
RNAse free water. RNA quantity was determined by 
spectrophotometry (A260/280), and RNA quality was determined by 
gel electrophoresis. Later, mRNA was isolated from the total RNA 




Suppression subtractive hybridization 
 
Suppression subtractive hybridization analysis was performed using 
the SMART-PCR select cDNA hybridization kit, according to the 
manufacturer’s recommendation (Clontech, Mountain View, CA, 
USA). Between 2 to 4 µl (2 µg) of mRNA was used for the synthesis 
of first strand cDNA from samples that were identified as gamma-
irradiated and non-irradiated sporozoites. To each sample, 1.0 µl of 
cDNA synthesis primer was added and enough water to bring the 
final volume of each reaction mixture to 5.0 µl as indicated by the 
manufacturer of the SMART-PCR select cDNA hybridization kit 
(Clontech). The second strand cDNA was synthesized following the 
manufacturer’s recommendation (Clontech).  The samples were 
digested with Rsa I restriction enzyme to generate samples with 
blunt ends. A 1:5 dilution of digested cDNA pool was made. Each 
cDNA pool from IEEF and NIEEF was divided into two tester or 
experimental cDNA pool (1 and 2) and driver or reference cDNA 
pool. 2.0 µl of diluted tester cDNA pool identified as 1 and 2, were 
ligated with adaptors 1 and 2 that contain PCR priming sites. The 
adaptor ligated tester cDNAs were subjected to two cycles of 
subtractive hybridization using irradiated driver (ID) cDNA NIEEF 
and non-irradiated driver (NI-D) cDNA for irradiated tester (IT) 
cDNA to eliminate mRNAs that are common to both the irradiated 
(I) and non-irradiated (NI) cDNA pool. Meanwhile, because the 
driver cDNA was not ligated to adaptors or PCR priming sites, the 
tester-driver cDNA hybrids possessed only a single priming site that 
made them unavailable for subsequent PCR amplification. Hence, 
transcripts for housekeeping genes that are common to the 
irradiated and non-irradiated cDNAs were subtracted from the 
cDNA pools. In this way, in the final round of hybridization, tester 1 
and 2 cDNA pools were combined so that the hybridization will 
produce subtracted irradiated and subtracted non-irradiated cDNA 
that contains only differentially expressed cDNA transcripts. 
Differential Screening kits (Clontech Laboratories and Inc.) were 
used to enrich and identify differentially expressed genes in the 
driver and tester cDNA samples. Both forward and reverse 
subtraction were performed with the non-irradiated cDNA serving as 
driver and the irradiated cDNA serving as the tester (cDNA pools 
from which specific genes are to be identified) in one reaction while 
in the other reaction, the irradiated cDNA was the driver (cDNA 
pools used to selectively remove non-differentially expressed genes 
from the tester DNA) while the non-irradiated cDNA was the tester. 
Irradiated cDNA pool (2 µg) without adaptors was added to the non-
irradiated sample as the driver while non-irradiated cDNA pool (2 
µg) also without adaptors was added as driver to the irradiated 
cDNA tubes. These samples were subjected to two steps of 
subtractive hybridization to eliminate sequences that are common 
to both cDNA.  
 
 
PCR amplification of differentially regulated genes 
 
To amplify and enrich for differentially expressed mRNAs, primary 
PCR was used to exponentially increase the subtracted IEEF and 
the  subtracted  NEEF  cDNA  libraries  that  have  different adaptor  
 
 




sequences ligated to them. Later, 1.0 µl aliquot of the primary PCR 
product was used in nested PCR to further enrich for differentially 
expressed sequences as well as reduce background effect by using 
the SMART-PCR select cDNA hybridization protocol with a slight 
modification on the number of PCR cycles. The primary PCR 
reaction was increased to 35 cycles, while the nested PCR reaction 
was increased to 24 cycles rather than the manufacturers 
recommended 27 and 12 cycles. Primers for the following gene 
products were used as positive controls: MSP-1, AMA, 28S-rRNA, 
and Hep-17. An aliquot of the nested PCR product was purified on 
a 2% agarose gel with 1.0 µg/mL of ethidium bromide. Two micro 
liters of the nested PCR product was added to TOPO vector 
(Invitrogen, Carlsbad, CA) and incubated for 5 min at 24°C.  
 
 
Cloning of differentially expressed cDNA 
 
Two micro liters of the cloned product was used to transform TOP 
10 One Shot
™ 
Chemically Competent E. coli cells (Invitrogen, 
Carlsbad, CA). Transformed bacteria were selected by the blue 
(insert negative) and white (insert positive) colony selection criteria 
in combination with PCR amplification using vector specific T7 
promoter primers to confirm successful transformation. Insert 
positive colonies were subcloned to agar plates with X-gal (50 
mg/ml) and ampicillin (1.0 µl/ml) and incubated overnight at 37°C. 
Insert positive colonies were next incubated overnight at 37°C in 
5.0 mL of Luria broth. Template plasmid was spin column purified 
with an SV miniprep kit (Promega, Madison, WI). Sequencing was 
done using dye terminator method on a 373 automated fluorescence 
sequencing system (Applied Bio systems, Foster City, CA). 
Sequencing products were analyzed for template contamination by 
using the MACVECTOR program (Accelrys, San Diego, CA). To 
look for similarity to known protein sequences in GENBANK 
database, DNA sequences for the IEEF and the NIEEF were 
compared against the public database using BLASTX. Genetic 
identity was ascertained based on an E (expect) value of ≤ 0.05 
using a non-redundant Prot-ein tBlastX search. 
 
 
Validation of differential gene expression by cDNA dot blots 
hybridization 
 
To confirm differential gene expressions, candidate cDNA clones 
were subjected to differential screening, using the cDNA dot blot 
hybridization technique as recommended by the manufacturer 
(PCR select differential screening kit; Clontech).  One microliter of 
each non redundant irradiated and non-irradiated cDNA clone was 
PCR amplified using the M13 forward and reverse primers. Five 
microliter aliquots of the PCR products were denatured in an 
equivalent volume of 0.6 N sodium hydroxide as per the 
recommendations of the manufacturer of the differential screening 
kit (Clontech). Two µL of the denatured PCR products were 
transferred to four identical positively charged nylon membranes. A 
set of four identical dot blots of irradiated and non-irradiated PCR 
products were transferred to each of four membranes. The four dot 
blot membranes were identified as: (a) clones hybridized to the 
forward subtracted probe; (b) clones hybridized to the reverse 
subtracted probe; (c) clones hybridize to the forward un-subtracted 
probe; and (d) clones hybridize to the reverse un-subtracted probe. 
Blots were neutralized for 2-4 min with 0.5 M Tris-HCL (pH 7.5) and 
washed with water before cross-linking the DNA to the membrane 
with a UV linker (Stratagene). Each membrane was placed in a 
separate 50 mL conical tube and incubated for 60 min. at 60°C in 
10 ml of pre-hybridization buffer with continuous agitation. 
Membranes were later exposed overnight to subtracted and un-









isotope. The following day, the membranes were washed to final 
stringency with 0.1% SDS and 0.1% SSC (0.1x of 3M sodium 
chloride, 300 mM sodium citrate) for 15 min (2x) at wash 60
o
. 
Washed membranes were exposed overnight to Kodak Biomax MS 
X-ray film -80°C and autoradiography done using the automated 
medical film processor, QX-130A Plus (Konica, NJ, USA). 
 
 
Confirmation of differential gene expression by quantitative 
RT-PCR 
 
To validate the differential expressed and investigate up regulation 
and down regulation of some gene, total RNA obtained from gene 
products of gamma-irradiated and non-irradiated sporozoites were 
confirmed by semi quantitative RT-PCR analysis. First strand cDNA 
was synthesized from 3 µg of DNase treated total RNA in a 
standard reverse transcription (RT) reaction using the Superscript 
Oligo (dT) first-strand synthesis system for RT-PCR (Invitrogen). 
PCR was done for 35 cycles with 94°C as the denaturing 
temperature, 50°C as the annealing temperature and 72°C as the 
elongation temperature. PCR product was analyzed on a 2% 





Differential expression of subtracted IEEF and NIEEF 
 
Table 2A shows a summary of matches between 
sequences from the subtracted NIEEF cDNA clones and 
those of known proteins in a non-redundant database. 
Similarly, Table 2B is a summary of matches between 
sequences from the subtracted IEEF cDNA clones and 
those of known proteins in the database to which they 
also exhibited homology. Most sequences from the 
subtracted IEEF and NIEEF cDNA clones produced no 
match to known protein sequences in the non-redundant 
database (data not shown).  
 
 
RT-PCR analysis of in vitro derived EEFs 
 
To evaluate how results of our sequences relate to 
differential gene expression in the IEEF and NIEEFs, 
primers were synthesized from sequences of 10 of the 
104 randomly selected positive clones (Table 1) that 
displayed homology to those of the erythrocyte 
membrane protein gene, the yir gene, the tubulin tyrosine 
ligase gene and the p235 kDa rhoptry protein gene. 
These primers were used in a semi quantitative RT-PCR 
assay to evaluate total RNA from IEEF and NIEEFs that 
were axenically cultured at 37°C for 24 h. Figure 1 shows 
RT-PCR products from the IEEF and NIEEF samples. In 
each case, the amplified gene displayed a fluorescence 
intensity that was proportional to the amount of mRNA 
that was synthesized and is characterized by abrogation 
of the erythrocyte membrane protein (EMP) gene in the 
IEEF and up regulation of the said gene in the NIEEF. 
The   fluorescence    intensity   of    the    yir    gene   was  
 
 




Table 1. Clones with their Sense and Anti-sense primer sequences that were used in this Study. 
 
Clone Sense primers Anti-sense primers 
1NI 2-12 TAAGTTGGGTAACGCCAGG TCGCTGTTTGCCTCATTG 
2NI 2-12 TAAGTTGGGTAACGCCAGG CGCACAAACAAAAACCGAC 
DI 2-5 CGGTTGCTATGCTAAGAACAGC TTCATTGTGCTCACCTCAGG 
NI 2-19 TGTTGTGTGAAATGTGAGCG TGACGGTTTTGATGGTAGAGG 
DNI 2-6 CGTTACTCTTTTGGAGGCG ATAGGTGGGAGGCAGTGAAG 
4I 1-1 TTAGGACAGTCAGGAGGTTCAG ATAAGCAATGAGCGATGTGG 




Table 2A. Randomly selected positive cDNA clones from subtracted NIEEF whose sequences were compared against the 
public database using BLASTX. Genetic identity based on an E value of ≤ 0.05 show ESTs with their corresponding contigs.  
 
Non-irradiated clones Contig Identified protein 
NI 1-5 Malpy02019 CCAAT-box DNA binding protein 
NI 1-11 Malpy01430 235 kDa rhoptry protein 
NI 1-12 Malpy00905 Putative bir1 
NI 2-14 Malpy02672 Ribosomal protein S4 
NI 2-10 Malpy00013 Uncharacterized protein family 
NI 2-12 Malpy00271 Erythrocyte membrane protein 
NI 2-2 Malpy00014 Putative uncharacterized protein family 
NI 2-19 Malpy00954 Putative yir4 protein 
NI 1-1 Malpy02241 Hypothetical protein 
DNI 2-3 Malpy01423 Heat shock protein 60 
DNI 2-7 Malpy00271 Uncharacterized protein family 




Table 2B. Randomly selected positive cDNA clones from subtracted IEEF whose sequences were also compared 
against the public database using BLASTX. Shown are ESTs with contigs that are based on an E value of ≤ 0.005. 
 
Irradiated clones    Contig Protein Identified 
I 1-4 Malpy000471 Hypothetical protein 
DI 2-2 Malpy01825 Hypothetical protein 
DI 2-11   Malpy00500 Putative yir1 protein 
DI 2-5 Malpy00137 Putative yir4 protein 
DI 1-12   Malpy00664 Tubulin-tyrosine ligase family 
DI 2-2 Malpy01557 Putative yir4 protein 
I 1-6 Malpy01953 Hypothetical protein 
DI 1-15   Malpy01115 Uncharacterized protein family 
DI 2-15   Malpy00137 Putative yir3 protein 
DI 2-9 Malpy00296 hypothetical protein 




characterized by up regulation in the NIEEF and down 
regulation in the IEEF, while in the case of the tubulin 
tyrosine ligase gene, the fluoresce intensity was 
characterized by down regulation  in  the  NIEEF  and  up 
regulation of the said gene in the IEEF. Amplicons for the 
gene that codes for p235 kDa rhoptry protein displayed a 
fluorescence intensity that was similar in the IEEF and 
the NIEEF despite  the  exposure of the IEEF sporozoites  
 
 






Figure 1. Semi-quantitative RT-PCR analysis of positive P. yoelii cDNA clones 
that were identified as differentially regulated because of gamma-irradiation. RNA 
from NIEEF and IEEF was used for first strand cDNA synthesis. Using clone-
specific primers (Table 1) and cDNA as template, PCR amplification produced 




to 12 Krads of radiation.  
 
 
Validation of differential expression 
 
Figure 2, demonstrates a strong hybridization signal in 
panel B between the subtracted IEEF cDNA dot blots and 
the subtracted total cDNA probes, while in panel A where 
the subtracted IEEF cDNA dot blots were probed with un-
subtracted total cDNA probes, a weak hybridization 
signal was observed in the two membranes. Between the 
subtracted IEEF cDNA dot blots and the subtracted total 
cDNA probes, 94 of 104 (90%) clones exhibited a strong 
hybridization signal, an indication of the high efficiency of 
the SSH technique. 




d-ATP isotope labelled 
probes were used to probe 104 cDNA dot blots on four 
other separate nylon membranes as shown in Figure 3. 
These samples were randomly selected from subtracted 
NIEEF cDNA clones. Once more, like in Figure 2, a 
strong hybridization signal is observed in panel B 
between the subtracted NIEEF cDNA  dot  blots  and  the 
subtracted total cDNA probes while a weak hybridization 
signal is observed in panel A in the reaction between the 
subtracted NIEEF cDNA dot blots and the un-subtracted 
total cDNA probes. 
 
 
RT-PCR analysis of in-vivo derived EEFs 
 
No amplicons were observed when the same sets of 
primers were used to test blood that was infected with P. 
yoelii (Figure 4). Based on the differential display pattern 
of these results, we were curious as to whether there was 
any analogy of our results to that which was obtained 
with the yir gene by comparing the sequences from our 
five clones to those of known Plasmodium proteins in a 
non-redundant database. The result obtained showed 
homology but to proteins with unknown functions. 
Next, primers that were designed from using randomly 
selected sequences that belong to (+) and (-) clones from 
axenically derived cultures of the IEEF were used in 
another RT-PCR assay to evaluate liver samples from 
Balb/c mice that were infected with gamma irradiated and 
 
 






Figure 2. Validation of differential expression; PCR amplicons of insert positive clones that were 
denatured in 6N NaOH were analyzed on positively charged nylon membranes and probed with 
indicated probes. The plus (+) and minus (-) signs denote candidate cDNA clones of P. yoelii IEEF 
genes that were apparently up and down regulated in response to gamma-irradiation. SD and IN 




non-irradiated sporozoites. At day five post Balb/c mice 
infection (Figure 4A) is a comparative analysis of the RT-
PCR assay result, with “N” denoting amplicons from the 
liver of the Balb/c mice that was infected with non-
irradiated sporozoites and “I” denoting amplicons from 
the liver of the Balb/c mice that was infected with 
sporozoites that were exposed to 12,000 rads of 
radiation. The conclusion from this study is that arrest in 
the development of the IEEF in hepatocytes is not an 
event that occurs suddenly. This can be explained by the 
fact that following attachment and invasion of 
hepatocytes by sporozoites, both the IEEF and the 
NIEEF undergo similar transformational changes from 
sporozoites to trophozoites. Subsequently, while the 
transformation of the NIEEF progresses to the 
trophozoite then the schizont stage, the transformation of 
the IEEF becomes arrested at the trophozoites stage. 
This explains why at day five post Balb/c mice infection, 
gene expression in the Balb/c mice inoculated with non-
irradiated sporozoites and the Balb/c mice inoculated with 
irradiated sporozoites were the  same  following  invasion  
of hepatocytes (Figure 4B).  
Next, a third Balb/c mouse was infected with 
sporozoites that were dissected from the salivary glands 
of mosquitoes that were exposed to 12,000 rads of 
gamma radiation. Twelve days post infection, blood was 
drawn from the mice and RT-PCR assay was done on 
the sample with the primers that were designed from 
using randomly selected sequences that belong to (+) 
and (-) clones from axenically derived cultures of the 
IEEF. This time around, no bands were detected in the 
blood samples except in lane seven where Hep-17 
(Wang et al., 2004) was used as positive control, 
confirming the fact that no breakthrough occurred 
following the adequate exposure of sporozoites to 12,000 
rads of gamma radiations as the development of the 
IEEF does not proceed beyond the trophozoite stage 





Suppression  subtractive  hybridization is a technique that  
 
 






Figure 3. Validation of differential expression; PCR amplicons of insert positive clones 
denatured in 6N NaOH were arrayed on positively charged nylon membranes and probed 
with indicated probes. Lower two panels show successful enrichment of NIEEF 




is widely used to study differential gene expressions in 
cells. It was used in this study to identify cDNA clones 
that expressed genes or gene products that are uniquely 
of sporozoites that were axenically cultured at 37C for 
24hrs as IEEF and NIEEF as well as to decipher the 
molecular basis for the arrest in the developmental of 
sporozoites at the liver-stage that were exposed to 
12,000 rads of gamma radiation. Consequently, based on 
homology studies that resulted in the assigning of 
putative identity and function to our sequences, the  data 
obtained revealed a modifying effect of irradiation on 
gene expression profiles of proteins in the IEEF in terms 
of immune response, mitosis, and receptor/epitope 
interaction (Figure 5C). 
A putative immune response factor identified in this 
study based on homology studies is known as the yir 
multigene family. This gene family has been determined 
to be sequentially expressed as sets of genes during 
different developmental stages of the malaria parasite.  
The complexity of the yir multigene family is 
characterized by the fact that it exists as about 838 allelic 
forms that are homologous to the vir multigene family that 
is found in Plasmodium vivax. In terms of being expressed 
as different sets of genes, the process usually is initiated 
in the mosquito vector by the initial expression of different 
sets of yir genes by sporozoite, and then it is continued 
inside the mammalian host where different sets of yir 
genes are expressed during the liver and blood stages of 
the parasite. These different sets of yir genes that are 
expressed at different developmental stages of the 
sporozoites are for them to be used to fulfil unique 
functional roles. In the salivary gland of mosquitoes, the 
functional role of the expressed yir gene are for use to 
complement the activities of other stored proteins like 
those of the micronemes, rhoptry bodies and dense 
granules. When inoculated into the mammalian host, the 
role of yir gene products are to facilitate traversal motility 
as well as for attachment, invasion and development in 
hepatocytes. This expression of different sets of yir genes 
will continue with merozoites that are released from 
hepatocytes as YIR proteins have been identified on the 
surface of erythrocytes where they are associated with 
immune evasion. Demonstrating once more that, the set 
of yir genes that are being differentially expressed at 
each stage in the life cycle of sporozoites are for the 
purpose of  fulfilling  unique functions, key amongst which  
 
 






Figure 4A. RT-PCR assay with primers design from sequences of a random 
selection of the IEEF plus (+) and minus (-) clones were used to test liver samples 
infected with gamma-irradiated sporozoites (I) and non-irradiated (NI) sporozoites as 
well as blood samples infected with non-irradiated sporozoites. Amplicons are 






Figure 4B. Sequences from known antigens of EEF were used to generate primers 
that serve as control for the RT-PCR assay in Figure 4A. Noted here are amplicons 










Figure 4C. No amplified PCR product is observed in the blood sample. Lane 




is the production of variant immune antibodies that are 
critical for used in immune evasion and for pathogenesis 
in the host. However, because there was down regulation 
of the yir gene in the IEEF as observed in this study, 
coupled with the fact that studies have shown irradiated 
sporozoites as having the propensity to invade 
hepatocytes during which their development becomes 
arrested at the trophozoite stage shows that yir multigene 
family has roles that are associated with sporozoite 
attachment and invasion of  hepatocytes.  The implication 
of this is that the product of the yir multigene family can 
be a suitable candidate for use in a multi-subunit vaccine 
to prevent malaria at the pre-erythrocytic stage.   
Another putative immune response factor identified 
from homology studies of sporozoite sequences was the 
py235 gene product that appears to be initiated at the 
trophozoite stage through to schizogony. The gene exits 
also as a multigene family with 11 – 50 allelic forms. 
Preiser et al. (1999 observed that each merozoite from 
schizonts formed inside the parasitophorous vacuoles of 
hepatocytes, expresses a py235 gene that is unique from 
that of other merozoites With 10,000 – 30,000 merozoites 
per schizont (Druilhe et al., 1998) and the fact that there 
are literally thousands of schizonts that are formed inside 
infected hepatocytes of the liver, demonstrates that the 
products of the py235 gene provides the EEF with means 
of protection against immune pressures from the host 
(Lyer et al., 2007). Moreover, expression characteristics 
suggest that transcriptional and translational machinery 
involve multiple members of the py235 multigene family. 
And since each merozoite in a schizont expresses a 
unique py235 phenotype the possibility of irradiation 
affecting all variants of the py235 genes is minimal. As a 
result, genes not affected by sporozoite exposure to 
12,000 rads of gamma radiation will be expressed later at 
the liver stage by both the IEEF and the NIEEF. This 
explains why expression of the py235 gene was similarly 
detected in the IEEF and the NIEEF because it will 
appear that transformation as a continuously evolving 
process gradually coalesces in the general shift in gene 
expression from the liver-stage-like to the blood-stage-
like in the malaria parasite. Moreover, the fact that the 
IEEF following exposure to 12,000 rads of gamma 
radiation could still develop in parasitophorous vacoules 
that only measure 4-8 µm in diameter because sporozoite 
development has become arrested at the trophozoite 
stage in parasitophorous vacuoles means the py235 
multigene family codes for protein products with varied 
functions amongst which are protein products that may 
be utilize for attachment and invasion as well as for 
sporozoite development in hepatocytes. As such, this 
qualifies   products   of   the  py235   multigene  family  as 
 
 










possible candidates for use in a multi-subunit vaccine to 
prevent sporozoites from attaching and invading 
hepatocytes at the pre-erythrocytic stage.   
Meanwhile, another putative immune factor identified 
from homology sequence study was that of the 
erythrocyte membrane protein 1 (EMP1) that is coded for 
by var multigene family. Two-third of this gene family is 
located at the ends of chromosome 14 and in the internal 
regions of chromosomes 4, 7, 8, and 12. The EMP1 is a 
variant protein in terms of its antigenicity and molecular 
size (200-350kDa). It is known to be compose of 2 to 7 
Duffy-binding like (DBL) domains with each containing 5 
cysteine-rich-interdomain regions (CIDR) (Claessens et 
al., 2014). Previously, the var multigene family was 
thought to be active mostly during the erythrocytic stage 
of malaria because they were found to be associated with 
pathogenicity and immune evasion (Senczuk et al., 
2001).  However, today, studies have shown that the var 
multigene family is expressed in mosquitoes, starting 
from the oocyst stage rather than from the stage when 
gametocytes are taken up by mosquitoes and then they 
transform into the ookinetes. During activation of these 
family of genes in  oocysts,  of  a  total  of  60  known  var 
genes, only one is activated to code for the EMP1, while 
the remaining 59 var genes are kept in an inactive state. 
This type of activation in the oocyst stage will remain in 
this manner through the sporozoite stage. This is 
significant because the oocyst is the stage in the 
mosquito during which sporozoites are formed and later 
released into the salivary gland in preparation for 
inoculation into a mammalian host during a blood meal. 
Which shows that the role played by var genes in terms 
of pathogenesis are only limited to the erythrocytic stage 
as the sporozoites stage is a silent phase of malaria 
during which no sign and symptom are manifested 
following inoculation of sporozoites into the mammalian 
host (Gomez-Diaz et al., 2017). It will appear that like in 
the case with the CS and TRAP proteins, the EMP1 is 
involve in traversal, attachment and successful invasion 
of hepatocytes especially as these processes require 
receptor/epitope interaction that involves ligands on the 
surface of sporozoites with several receptors on the 
surfaces of various cells on the mammalian host 
(Matuschewski et al., 2002). However, the unique 
receptor on the surface of hepatocytes to which 
sporozoites  can  bind   using   the  EMP1  protein  is  still  
 
 




controversial as while some studies conclude that 
Plasmodium yoelii and Plasmodium falciparum use the 
EMP1 ligand to bind to CD81receptor on the surface of 
hepatocytes, others conclude that the receptor used is 
the scavenger receptor BI (SR-BI) for invasion and 
development inside parasitophorous vacuoles of 
hepatocytes. These conclusions were arrived at partly 
because antibodies directed against the SR-BI and CD81 
receptor prevented sporozoites from invading 
hepatocytes with the EMP1 ligand (Yalaoui et al., 2008). 
Later, with the release of merozoites and the initiation of 
the erythrocytic stage, the binding of EMP1 on the 
surface of erythrocytes to ICAM-1 and CD36 on the 
surface of host endothelial cells results in sequestration 
that causes the most life-threatening form of malaria 
known as cerebral malaria (Chen et al., 1998; Zanghi et 
al., 2018). The fact that in this study expression of the 
gene that codes for EMP1 was abrogated in cDNA clones 
from the libraries of the IEEF and the parasites could still 
invade hepatocytes where their development became 
arrested in parasitophorus vacuoles that only measure 4-
8 µm demonstrates that when it comes to attachment and 
invasion of hepatocytes, sporozoites may be utilizing 
redundant mechanisms to achieve this process. This is 
because if the var gene peptides were the sole entities 
utilize by sporozoites for attachment and invasion of 
hepatocytes, then once abrogated as was the case in the 
IEEF, the sporozoites should not be able to enter 
hepatocytes to form parasitophorous vacuoles that only 
measure 4-8 µm in diameter (Scheller et al., 1995), 
demonstrating that the trophozoite phase gradually 
transitioned into the schizogony phase. And the fact that 
expression of the EMP gene was only observed in the 
cDNA clones of the NIEEF as oppose to the cDNA clones 
of the IEEF also corroborates the finding that gene 
expression in the malaria parasite shifts from liver-stage-
like to blood-stage-like Robson et al. (1995). 
The final gene identified in this study was that which 
codes for the enzyme tubulin tyrosine ligase. This 
enzyme shows preference for tubulin, which is a protein 
that has a genome that contains one gene that codes for 
β-tubulin subunit and two genes that code for α-tubulin 
subunit (Prota et al., 2013). When products from these 
genes are configured inside sporozoites, the result is the 
formation of a protein known as tubulin that serves as a 
basic building block for structures with different 
functionalities inside sporozoites. In one configuration 
involving the basic building blocks, the gene products are 
arranged end-to-end to form a tube shape heterodimer in 
which an alpha subunit and a beta sub-unit of the basic 
building block alternate with each other in such a manner 
that when one end terminates with the alpha sub-unit, the 
other begins with the beta sub-unit. In a second 
configuration involving the basic building block, the gene 
products are initially assembled to produce tube-like 





of alternating α-tubulin and β-tubulin serve as walls of 
microtubules while the carboxy-terminal tails that 
protrude from the wall function as sites that can later be 
modified for attachment of microtubule associated 
proteins. In these configurations, the α/β tubulins are not 
only organized so that they become building blocks for 
microtubule, but they are organized in such manner that 
modifications can occur on the building blocks as well as 
on the carboxy terminal to generate a variety of 
microtubules with organelle-specific function and 
properties (Hammond et al., 2008). Featuring prominently 
in these changes that generate microtubules with 
different functionalities is post-translational modification 
of the wall that is compose of tubulin heterodimer by way 
of tyrosination/detyrosination (Gundersen et al., 1987) as 
well as modification of the carboxy terminal that will 
generate microtubules with very divers functions that 
include but are not limited to functions involving changes 
of cell shape, movement of vesicles with synthesized 
proteins from the rough endoplasmic reticulum to the 
golgi apparatus, movement of organelles and granules 
from one part of a cell to another,  and chromosomes by 
way of specially attached proteins  (Prota et al., 2013). 
The tyrosination/ detyrosination modification involves 
detyrosination which is the removal of a tyrosine residue 
from the c-terminal of α-tubulin by tubulin 
carboxypeptidase and occurs predominantly on polymeric 
tubulin while tyrosination involves the re-attached of 
tyrosine to unassembled α-tubulin by tubulin tyrosine 
ligase (Ersfeld et al., 1993; Hallak et al., 1977; 
Lafanechere et al., 1998). They are stimulated by 
microtubule-binding proteins to form microtubules. 
Shortly after the microtubules become stabilized, they 
accumulate as post-translationally modified tubulin better 
known as de-tyrosinated tubulin. Polymerized tubulins in 
microtubules are the main constituent of mitotic spindles, 
basal bodies of flagella because the α/β tubulins are 
organized in a manner that makes them to be building 
blocks for used to generate microtubule structures with 
organelle-specific function and properties (Masuda and 
Shibata 1996). The up regulation of the gene that codes 
for tubulin tyrosine ligase in the cDNA clones from the 
IEEF implies that exposure of sporozoites to 12,000 rads 
of radiation may have resulted in an increase in the 
synthesis of tubulin. This is significant because tubulin 
tyrosine ligase exclusively modifies unpolymerized tubulin 
whose increase in a cell results in unstable microtubules 
as oppose to depolymerized tubulin that results in stable 
microtubules Magiera and Janke (2014). As such, the 
arrest in the development of sporozoites inside 
hepatocytes can be explained by the fact that up 
regulation of the gene that codes for tubulin tyrosine 
ligase has resulted in an increase in the concentration of 
tyrosinated tubulin in sporozoites at the expense of 
detyrosinated tubulin thereby disrupting the tyrosination/ 







the development of sporozoites (Gundersen et al., 1987). 
For that the product of this gene can be a suitable 
vaccine candidate for use in a multi-subunit vaccine to 
prevent malaria during the silent phase of the disease. 
Arrested development having left the parasite in a 
perpetual trophozoite phase means the expression of the 
tubulin tyrosine ligase gene is constitutive due to the 
possible lack of genetic information that will signal the 
trophozoite to transition to the next developmental phase 
of the malaria parasite. Down regulation of the said gene 
in the cDNA clones of the NIEEF can be attributed to the 
fact that the trophozoite phase immediately transitioned 
into the schizogony phase after mitosis and cytokinesis 
that is marked by DNA replication and the formation of 
thousands of merozoites. 
Meanwhile, to further validate our results from the 
suppression subtractive hybridization technique, do blot 
preparations from the original two P. yoelii cDNA libraries 





 d-ATP labeled total cDNA probes 
that were subtracted as well as un-subtracted. 
Autoradiography demonstrated that a majority of the 
subtracted NIEEF cDNA clones exhibited up regulation 
as compared to those of the subtracted NIEEF cDNA 
clones. Next to understand the significance of the pattern 
of display of the PCR product in Fig. 5 Primers from 
selected clones were used in another RT-PCR analysis 
involving irradiated sporozoites, non-irradiated 
sporozoites and blood from mouse that was infected with 
Plasmodium yoelii parasites. Electrophoresis on a 2% 
agarose gel shows differential display of bands whose 
sequences would neither confirm yir, tubulin tyrosine 
ligase nor p235 rhoptry protein. This is an indication that 
more cDNA clones need to be selected for use to 
synthesize primers for the RT-PCR assay. 
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